Mgtta Medical Devices & Lab Equipment Accelerates Global Export Layout

2026-05-09

Jinan, May 9, 2026 — China’s medical device exports maintain a steady growth momentum. According to data from the China Chamber of Commerce for Import and Export of Medicines and Health Products, China’s medical device exports reached USD 50.469 billion in 2025, with exports hitting USD 12.585 billion in the first quarter of 2026, a year-on-year increase of 8.92%. The industry is evolving toward high-end development, intelligent manufacturing and global market expansion.

As a professional manufacturer specializing in the R&D, production and export of medical devices and laboratory equipment, Mgtta seizes industry development opportunities. Supported by strong technical strength, a comprehensive product portfolio and a global service system, the company continues to expand its market share worldwide, enabling high-quality Chinese intelligent manufacturing medical products to go global.

Global demand for healthcare resources keeps rising, with robust market demand for cost-effective and high-standard medical devices and laboratory equipment across Belt and Road countries, RCEP regions and European and American markets.

In Q1 2026, China’s medical device exports to RCEP member states rose 9.83% year on year, and the Belt and Road region has become a core growth driver for overseas sales.

Against this backdrop, Mgtta accurately caters to global market demands, focusing on four core product lines: laboratory analytical instruments, medical diagnostic equipment, rehabilitation care devices, and medical consumables. Its products are widely applied in clinical diagnosis and treatment, medical testing, scientific research and public health services, serving hospitals, medical institutions, research institutes and third-party testing organizations worldwide.

Quality & Certification

Technological innovation lies at the core of Mgtta’s global competitiveness. Adhering to the pHilosophy ofinnovation-driven development and quality supremacy, the company continuously increases R&D investment and breaks through multiple key core technologies.

A full range of products have obtained authoritative international certifications including CE certification, FDA registration and ISO 13485 medical quality management system certification, fully meeting the market access standards of mainstream global regions.

Self-developed products such as automatic biochemical analyzers, high-precision PCR detectors and intelligent rehabilitation training equipment have won wide recognition from overseas clients for stable performance, accurate detection results and user-friendly intelligent operation. The complete series of laboratory equipment and supporting consumables enjoy outstanding cost performance, perfectly matching the needs of primary medical institutions and scientific research scenarios in different countries. At present, Mgtta’s products are sold to more than 80 countries and regions across Southeast Asia, the Middle East, Europe and Latin America.

In terms of international layout, Mgtta has built a full-chain overseas development model covering product export, brand operation and localized after-sales service. The company actively participates in top global medical exhibitions including Canton Fair, MEDICA Germany and FIME USA, establishing direct communication with overseas buyers to accurately capture market demands and expand international cooperation channels.

Meanwhile, Mgtta has set up a sound global marketing network and localized service team, providing one-stop solutions including product customization, technical training, installation and commissioning, as well as after-sales maintenance. It responds rapidly to customer needs, eliminates service concerns and builds long-term brand reputation and customer loyalty.

“The Chinese medical device industry is transforming from export by scale to quality-driven and brand-driven globalization, with high-end upgrading, intelligent iteration and international layout being irreversible trends,” said the overseas business director of Mgtta.

“As a professional manufacturer and exporter in this sector, Mgtta will keep focusing on technological innovation and product upgrading to strengthen core competitiveness. We will further explore global segmented markets, optimize our international service system, and meet the diversified demands of global clients with premium products and professional services. We are committed to promoting Chinese medical devices and laboratory equipment to the world, and contributing to the development of global healthcare undertakings.”

With the continuous expansion of the global healthcare industry and the rising international competitiveness of Chinese medical enterprises, Mgtta, as a leading export manufacturer, will further capture global market share by virtue of its advantages in technology, products and services, leading China’s medical device exports into a new stage of high-quality development.